Pharmacies Want Class Cert. In Pfizer Pay-For-Delay Case

Law360, New York (February 14, 2014, 8:30 PM EST) -- A group of pharmacies urged a Tennessee federal judge on Wednesday to reconsider his refusal to certify classes of drug retailers targeting a pay-for-delay deal that suppressed competition to a muscle relaxant made by a unit of Pfizer Inc., saying the similarities among the class members outweighed the differences.

The pharmacies said that U.S. District Judge Curtis L. Collier wrongly concluded that the proposed California, Michigan, Mississippi and New York classes couldn't be certified because some plaintiffs were multistate chain pharmacies, and it wasn't clear where they...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.